A novel adenosine analog, AMP579, inhibits neutrophil activation, adherence and neutrophil-mediated injury to coronary vascular endothelium

Author: Nakamura M.   Zhao Z.-Q.   Clark K.L.   Velez D.V.   Guyton R.A.   Vinten-Johansen J.  

Publisher: Elsevier

ISSN: 0014-2999

Source: European Journal of Pharmacology, Vol.397, Iss.1, 2000-05, pp. : 197-205

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract